{
    "applicationNumber": "BR 11 2022 022590-3",
    "filingDate": "07/05/2021",
    "grantDate": null,
    "title": "FORMULA\u00c7\u00d5ES FARMAC\u00caUTICAS DE ACETATO DE ABIRATERONA E NIRAPARIBE",
    "nationalPhaseDate": [
        "07/11/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2021/062188",
        "pctDate": "07/05/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "EP",
            "priorityNumber": "20173749.1",
            "priorityDate": "08/05/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/142,919",
            "priorityDate": "28/01/2021"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/174,282",
            "priorityDate": "13/04/2021"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2706"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2710"
        }
    ],
    "inventors": [
        "THOMAS RONALD A QUINTEN",
        "URBAIN ALFONS C DELAET",
        "PHILIP ERNA H HEYNS",
        "TATIANA MARCOZZI",
        "JOHNY BERTELS",
        "KATRIEN LUYTEN",
        "KAUSTUBH RAMESH TAMBWEKAR",
        "ANGELA LOPEZ",
        "PAUL J A HARTMAN KOK"
    ],
    "holders": [
        79692
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 9/16",
        "A61K 31/58",
        "A61K 31/573",
        "A61K 9/20",
        "A61K 31/454"
    ]
}